Workman P - Search Results

1

Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone.

Workman P. Workman P. Cancer Lett. 2004 Apr 8;206(2):149-57. doi: 10.1016/j.canlet.2003.08.032. Cancer Lett. 2004. PMID: 15013520 Review.

2

Tyrosine kinase inhibitors.

Workman P, Brunton VG, Robins DJ. Workman P, et al. Semin Cancer Biol. 1992 Dec;3(6):369-81. Semin Cancer Biol. 1992. PMID: 1286158 Review.

3

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.

Mbidde EK, Selby PJ, Perren TJ, Dearnaley DP, Whitton A, Ashley S, Workman P, Bloom HJ, McElwain TJ. Mbidde EK, et al. Among authors: workman p. Br J Cancer. 1988 Dec;58(6):779-82. doi: 10.1038/bjc.1988.308. Br J Cancer. 1988. PMID: 2852028 Free PMC article.

4

Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.

Lohmeyer M, Workman P. Lohmeyer M, et al. Among authors: workman p. Br J Cancer. 1995 Aug;72(2):277-86. doi: 10.1038/bjc.1995.325. Br J Cancer. 1995. PMID: 7640206 Free PMC article.

5

Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphorase.

Brunton VG, Steele G, Lewis AD, Workman P. Brunton VG, et al. Among authors: workman p. Cancer Chemother Pharmacol. 1998;41(5):417-22. doi: 10.1007/s002800050760. Cancer Chemother Pharmacol. 1998. PMID: 9523739

6

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90.

Kelland LR, Sharp SY, Rogers PM, Myers TG, Workman P. Kelland LR, et al. Among authors: workman p. J Natl Cancer Inst. 1999 Nov 17;91(22):1940-9. doi: 10.1093/jnci/91.22.1940. J Natl Cancer Inst. 1999. PMID: 10564678

7

Discovering novel chemotherapeutic drugs for the third millennium.

Garrett MD, Workman P. Garrett MD, et al. Among authors: workman p. Eur J Cancer. 1999 Dec;35(14):2010-30. doi: 10.1016/s0959-8049(99)00280-4. Eur J Cancer. 1999. PMID: 10711243 Review.

8

Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone.

Clarke PA, Hostein I, Banerji U, Stefano FD, Maloney A, Walton M, Judson I, Workman P. Clarke PA, et al. Among authors: workman p. Oncogene. 2000 Aug 24;19(36):4125-33. doi: 10.1038/sj.onc.1203753. Oncogene. 2000. PMID: 10962573

9

Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis.

Hostein I, Robertson D, DiStefano F, Workman P, Clarke PA. Hostein I, et al. Among authors: workman p. Cancer Res. 2001 May 15;61(10):4003-9. Cancer Res. 2001. PMID: 11358818

10

Characterization of a human colorectal carcinoma cell line with acquired resistance to flavopiridol.

Smith V, Raynaud F, Workman P, Kelland LR. Smith V, et al. Among authors: workman p. Mol Pharmacol. 2001 Nov;60(5):885-93. doi: 10.1124/mol.60.5.885. Mol Pharmacol. 2001. PMID: 11641415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results